Skip to content
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d766531c-fcf2-4482-a333-e8acd3bc0978&Preview=1
-
Date
12/14/2010
-
Company Name
Cardiovascular Systems
-
Mailing Address
651 Campus Drive St.Paul, MN 55112
-
Company Description
Replidyne is a biopharmaceutical company focused on developing and commercializing innovative anti-infective products.
-
Website
http://www.replidyne.com
-
Transaction Type
Debt
-
Transaction Amount
$3,500,000
-
Transaction Round
Undisclosed
-
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
-
M&A Terms
-
Venture Investor
Undisclosed